Overexpression of semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5883-5890

  Chen, Ying ^a,b,c   Zhang, Lei ^a,b,c   Lv, Rui ^a   Zhang, Wen Qi ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^c National Clinical Research Centre of Cancer   (China)

Author keywords

Ascites; Macrophage; Ovarian cancer; Prognosis; Semaphorin4D

Indexed keywords

CD100 ANTIGEN; LEUKOCYTE ANTIGEN; SEMAPHORIN;

ADULT; AGED; CELL DIFFERENTIATION; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HUMAN; MACROPHAGE; MIDDLE AGED; MONOCYTE; NEOPLASM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADULT; AGED; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MACROPHAGES; MIDDLE AGED; MONOCYTES; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; SEMAPHORINS;

EID: 84890535594     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5883     Document Type: Article

References (34)

1. Abdollahi T, Robertson NM, Abdollahi A, et al (2003). Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3. Cancer Res, 63, 4521-6.
2. Auersperg N, Ota T, Mitchell GW (2002). Early events in ovarian epithelial carcinogenesis: Progress and problems in experimental approaches. Int J Gynecol Cancer, 12, 691-703.
3. Basile JR, Castilho RM, Williams VP, et al (2006). Semaphorin 4D provides a link between axon guidance processes and tumorinduced angiogenesis. Proc Natl Acad Sci U S A, 103, 9017-22.
4. Basile JR, Holmbeck K, Bugge TH, et al (2007). MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem, 282, 6899-905.
5. Bast RJ, Hennessy B, Mills GB (2009). The biology of ovarian cancer: New opportunities for translation. Nat Rev Cancer, 9, 415-28.
6. Carmeliet P, Tessier-Lavigne M (2005). Common mechanisms of nerve and blood vessel wiring. Nature, 436, 193-200.
7. Chen Y, Zhang L, Pan Y, et al (2012). Over-expression of semaphorin4D, hypoxia-inducible factor-1a and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer. Int J Mol Sci, 13, 13264-74.
8. Ch'Ng E, Tomita Y, Zhang B, et al (2007). Prognostic significance of CD100 expression in soft tissue sarcoma. Cancer, 110, 164-72.
9. Delaire S, Billard C, Tordjman R, et al (2001). Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol, 166, 4348-54.
10. Denholm EM, Wolber FM, Phan SH (1989). Secretion of monocyte chemotactic activity by alveolar macrophages. Am J Pathol, 135, 571-80.
11. Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47.
12. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, et al (2008). The effect of maximal surgical cytoreduction on sensitivity to platinumtaxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol, 108, 276-81.
13. Giuntoli RN, Webb TJ, Zoso A, et al (2009). Ovarian cancerassociated ascites demonstrates altered immune environment: Implications for antitumor immunity. Anticancer Res, 29, 2875-84.
14. Ishida I, Kumanogoh A, Suzuki K, et al (2003). Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: Implications for the regulation of immune and inflammatory responses. Int Immunol, 15, 1027-34.
15. Jensen TO, Schmidt H, Moller HJ, et al (2009). Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. J Clin Oncol, 27, 3330-7.
16. Kumanogoh A, Kikutani H (2004). Biological functions and signaling of a transmembrane semaphorin, CD100/Sema4D. Cell Mol Life Sci, 61, 292-300.
17. Lan C, Huang X, Lin S, et al (2013). Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat, 12, 259-67.
18. Lane D, Matte I, Rancourt C, et al (2011). Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer, 11, 210.
19. Lee CH, Espinosa I, Vrijaldenhoven S, et al (2008). Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res, 14, 1423-30.
20. Martinez FO, Sica A, Mantovani A, et al (2008). Locati M. Macrophage activation and polarization. Front Biosci, 13, 453-61.
21. Nakanishi Y, Nakatsuji M, Seno H, et al (2011). COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis, 32, 1333-9.
22. Qian BZ, Pollard JW (2010). Macrophage diversity enhances tumor progression and metastasis. Cell, 141, 39-51.
23. Sakurai A, Doci CL, Gutkind JS (2012). Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res, 22, 23-32.
24. Sanchez-Espiridion B, Martin-Moreno AM, Montalban C, et al (2012) F. Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma. Haematologica, 97, 1080-4.
25. Shabo I, Olsson H, Sun XF, et al (2009). Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer, 125, 1826-1831.
26. Shabo I, Stal O, Olsson H, et al (2008). Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer, 123, 780-6.
27. Sica A, Larghi P, Mancino A, et al (2008). Macrophage polarization in tumour progression. Semin Cancer Biol, 18, 349-55.
28. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29.
29. Sierra JR, Corso S, Caione L, et al (2008). Tumor angiogenesis and progression are enhanced by Sema4D produced by tumorassociated macrophages. J Exp Med, 205, 1673-85.
30. van Dongen M, Savage ND, Jordanova ES, et al (2010). Antiinflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors. Int J Cancer, 127, 899-909.
31. Wang R, Zhang T, Ma Z, et al (2010). The interaction of coagulation factor XII and monocyte/macrophages mediating peritoneal metastasis of epithelial ovarian cancer. Gynecol Oncol, 117, 460-6.
32. Zhang B, Yao G, Zhang Y, et al (2011). M2-polarized tumorassociated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics (Sao Paulo), 66, 1879-86.
33. Zhang T, Ma Z, Wang R, et al (2010). Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells. Cancer Immunol Immunother, 59, 1097-108.
34. Zhou H, Binmadi NO, Yang YH, et al (2012). Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression. Angiogenesis, 15, 391-407.